| Literature DB >> 26100672 |
Mike R Russell1, Annalise Penikis1, Derek A Oldridge1, Juan R Alvarez-Dominguez2, Lee McDaniel1, Maura Diamond1, Olivia Padovan3, Pichai Raman4, Yimei Li1, Jun S Wei5, Shile Zhang5, Janahan Gnanchandran6, Robert Seeger6, Shahab Asgharzadeh6, Javed Khan5, Sharon J Diskin7, John M Maris7, Kristina A Cole8.
Abstract
Chromosome 6p22 was identified recently as a neuroblastoma susceptibility locus, but its mechanistic contributions to tumorigenesis are as yet undefined. Here we report that the most highly significant single-nucleotide polymorphism (SNP) associations reside within CASC15, a long noncoding RNA that we define as a tumor suppressor at 6p22. Low-level expression of a short CASC15 isoform (CASC15-S) associated highly with advanced neuroblastoma and poor patient survival. In human neuroblastoma cells, attenuating CASC15-S increased cellular growth and migratory capacity. Gene expression analysis revealed downregulation of neuroblastoma-specific markers in cells with attenuated CASC15-S, with concomitant increases in cell adhesion and extracellular matrix transcripts. Altogether, our results point to CASC15-S as a mediator of neural growth and differentiation, which impacts neuroblastoma initiation and progression. ©2015 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26100672 PMCID: PMC4526355 DOI: 10.1158/0008-5472.CAN-14-3613
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701